Step 1: Gather your supplies Before you begin, have everything within reach
Boehringer Ingelheim International GmbH (Emerging Leader) is classified as a rapidly emerging leader, with a focus on developing a novel GLP-1 agonist (Survodutide) in phase 3 of clinical development
My lab shrunk to, like, four people. When I asked his assistant if she remembers what it was like when the Pfizer paper came out, she sighed, looked down, and shook her head from side to side: That was devastating. Still, its hard to keep Sinclair down for long
Additional information Prior Presentation Findings from this study have been previously presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) in Atlanta, Georgia, USA, from 5 to 8 May 2024, and at the American Diabetes Association (ADA)84th Annual Scientific Sessions in Orlando, Florida, USA, from 21 to 24 June 2024